Fortress Biotech Inc (FBIO)

$2.77 +0.16 (6.13%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	86.70M
Revenue (ttm)	63.26M
Net Income (ttm)	6.82M
EPS (ttm)	N/A
PE Ratio	1.17
Forward PE	4.27
Profit Margin	10.78%
Debt to Equity Ratio	0.18

Volume	424,700
Avg Vol	432,698
Day's Range	N/A - N/A
Shares Out	33.22M
Stochastic %K	71%
Beta	1.22
Analysts	Sell
Price Target	$11.00

Company Profile

Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products. The company markets dermatology products, including Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe recalcitrant nodular acne; Amzeeq, a topical formulation of minocycline for inflammatory lesions of non-n...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 652 4500

Website: www.fortressbiotech.com

Address:

1111 Kane Concourse, Suite 301, Bay Harbor Islands, United States

Waters59 Jun. 5 at 12:36 AM

$FBIO I'll take $11-17 PT any day baby! Let's prove these analyst right, let's go! https://ca.investing.com/equities/coronado-bioscien-consensus-estimates

0 · Reply

Waters59 Jun. 4 at 8:09 PM

$FBIO wow, this board has been quiet today on a run up? Must be the shock. 😆 Let's get this to where it belongs, $4+.

0 · Reply